After 6 months 3 patients have now joined the extension trial.
20% of 54 evaluable patients recruited, Must be less than 25% - Maximum of 13 pateints I would think.
Even if ALL have made it to 6 months (almost impossible) that is 15% success ratio. Seems more likely less than 1/2 of these are evaluable at this stage, and if so a success ration of 30%.
Lets hope. Maybe happy days will soon be ahead.
Rgds KMS
VLA Price at posting:
23.0¢ Sentiment: LT Buy Disclosure: Held